Brookline, MA, United States of America

Yevgen Barsukov

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Yevgen Barsukov: Innovator in Cystic Fibrosis Treatment

Introduction

Yevgen Barsukov is a notable inventor based in Brookline, MA, who has made significant contributions to the field of medical research, particularly in the treatment of cystic fibrosis. With a total of five patents to his name, Barsukov's work focuses on developing innovative compounds that aim to improve the lives of patients suffering from this challenging condition.

Latest Patents

Among his latest patents, Barsukov has developed pyridazinone compounds and methods for the treatment of cystic fibrosis. One of his inventions relates to a compound with specific formulae designed to treat cystic fibrosis effectively. Another patent details methods of administering a therapeutically effective amount of a compound to patients in need, showcasing his commitment to advancing medical treatments.

Career Highlights

Yevgen Barsukov is currently associated with Flatley Discovery Lab, LLC, where he continues to push the boundaries of research and innovation. His work at the lab emphasizes the importance of developing new therapeutic options for patients with cystic fibrosis, reflecting his dedication to improving healthcare outcomes.

Collaborations

Throughout his career, Barsukov has collaborated with talented individuals such as Bridget McCarthy Cole and Richard Allen Nugent. These partnerships have likely contributed to the success of his research and the development of his patents.

Conclusion

Yevgen Barsukov stands out as an influential inventor in the realm of cystic fibrosis treatment, with a strong portfolio of patents that highlight his innovative spirit and dedication to medical advancement. His contributions are paving the way for new therapeutic options that could significantly benefit patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…